Monosodium glutamate: A hidden risk factor for obesity?
Obesity Reviews · 2025-06 · 26 (6)
DOI: 10.1111/obr.13903 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity Reviews, online erschienen am 06.02.2025. Verfasst von Ka Kahe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology and Department of Epidemiology, Columbia University Irving Medical Center, New York, NY, USA. Hauptthemen laut MEDLINE: Sodium Glutamate, Obesity, Food Additives, Sweetening Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Monosodium glutamate (MSG) has become one of the most widely used food additives in the global food supply. Although it has been classified for decades as a food ingredient that is generally recognized as safe, concerns about the health impacts of chronic MSG use, especially its potential effect on weight, are still ongoing. This comprehensive review summarizes the available human and animal evidence, highlighting potential mechanisms linking MSG use to weight gain or obesity, and discusses challenges and future research directions. Because of MSG intake worldwide as well as hidden MSG in food labeling, there is a pressing need for a mechanistic understanding of the health impacts of MSG use especially on weight. To generate robust scientific evidence and to clarify public concerns, rigorous mechanistic studies and randomized controlled clinical trials are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology and Department of Epidemiology, Columbia University Irving Medical Center, New York, NY, USA.
- Division of Endocrinology, New York Nutrition Obesity Research Center, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
- Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA.
- Department of Child and Adolescent Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.
- Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA.
ORCID-Profile: Ka Kahe
Förderung
- NIDDK NIH HHS
Zitieren
APA
Kahe, K., Laferrère, B., Castellanos, F. X., Zhang, Y., & Mozaffarian, D. (2025). Monosodium glutamate: A hidden risk factor for obesity?. Obesity Reviews, 26(6). https://doi.org/10.1111/obr.13903
Vancouver
Kahe K, Laferrère B, Castellanos FX, Zhang Y, Mozaffarian D. Monosodium glutamate: A hidden risk factor for obesity?. Obesity Reviews. 2025;26(6). doi:10.1111/obr.13903
BibTeX
@article{Kahe2025,
author = {Kahe, Ka and Laferrère, Blandine and Castellanos, Francisco X and Zhang, Yijia and Mozaffarian, Dariush},
title = {Monosodium glutamate: A hidden risk factor for obesity?},
journal = {Obesity Reviews},
year = {2025},
volume = {26},
number = {6},
doi = {10.1111/obr.13903}
}
EUVIMED